Founder accomplishments

Scientific work translated into protected and cleared technologies.

Selected publications, issued patents, and product-development contributions reflect Dr. Behnam's work before Applied Regeneration LLC established Applied Regenerative Therapeutics as its proprietary technology-development division. The listed patents, products, and FDA 510(k) clearances are not owned or held by Applied Regeneration LLC or Applied Regenerative Therapeutics, and no affiliation or endorsement by the referenced organizations is implied. They are presented solely as background on the founder's scientific experience relevant to the division's research leadership.

Publications

Peer-reviewed research and scientific chapters.

Review the founder's publication record spanning bone morphogenetic proteins, extracellular matrix biology, tissue processing, and regenerative product development.

View Publications

Founder's prior patent record

Selected patents naming Dr. Behnam as an inventor.

Technology platformPatentRepresentative invention

Demineralized Bone Matrix & Osteoinductive TechnologiesUS 9,415,136Osteoinductive Demineralized Cancellous Bone

Demineralized Bone Matrix & Osteoinductive TechnologiesUS 8,202,539Bone Matrix Compositions and Methods

Bone Morphogenetic Protein Delivery & RegulationUS 9,333,237BMP Binding Peptide

Bone Morphogenetic Protein Delivery & RegulationUS 9,610,320Surgical Application of BBP

Tissue Processing & Viral InactivationUS 8,642,061Viral Inactivation of Tissue Grafts

Bone Nanoarchitecture & Surface EngineeringUS 10,220,115Bone Matrix Nano-Textured Surfaces

Surgical Grafts & Implant TechnologiesUS 9,717,822Surgical Graft / Delivery System

Prior product translation

Prior contributions to FDA-cleared technologies.

Selected work performed before the founding of Applied Regenerative Therapeutics, spanning tissue-based products, spinal implants, additive manufacturing, and synthetic bone graft substitutes.

FDA 510(k)TechnologyRepresentative contribution

K082615Grafton II Enhanced DBM (MagniFuse®)Conceived the product concept and led scientific development and commercialization of the enhanced DBM platform, including biological characterization and support of FDA regulatory clearance.

K121316Alpine Adjustable Implant SystemSupported engineering efforts by identifying titanium plasma spray as the preferred surface treatment following characterization of osteoblast responses in tissue culture.

K171495Zyston Strut 3D-Printed Titanium CageInvestigated prototype failures using SEM and EDS, identified fracture nucleation associated with print-media contamination, and recommended alternative titanium media that resolved the issue.

K203218CaP Sphere Pellet PackDeveloped the formulation, final product configuration, and delivery system for a second-generation synthetic bone void filler, and supported manufacturing scale-up.

Founder-led R&D

Scientific experience supporting proprietary platform development.

Explore how Applied Regenerative Therapeutics applies its scientific foundation to internally designated regenerative technology programs.

Explore Our Platforms